PRMT5 and colorectal carcinoma: PRMT1, PRMT5, PRMT6, and PRMT7 have been shown to promote EMT in head and neck cancer, CRC, breast cancer, ovarian cancer, lung adenocarcinoma, and oral cancer cells [42].